Clinical Trials Logo

Clinical Trial Summary

Multicenter, non-interventional, retrospective/prospective biological study on patients affected by head and neck tumors, for which the collection and use of tissue samples, blood and saliva for the detection of HPV-DNA/RNA and miRNA.


Clinical Trial Description

For each patient they will come collected tissue, blood and saliva samples. In particular, as regards tissue collection, tumor and neighboring tissues will be used healthy specimens taken during surgical removal, according to clinical practice. The fresh tissues thus collected will be stored in RNA-later before freezing at - 80°C. Furthermore, blood and saliva samples will be taken at different times, in particular: i) the day before surgery; ii) the day after surgery (only for blood); iii) at the time of patient discharge (approximately 15 days after surgery); iii) during the check-up visit scheduled to monitor the patient's follow-up (FU): every 3 months for the first 2 years and every 6 months for the following 3 years. The samples will then be used to carry out nucleic acid extraction, the DNA will instead be used to detect the presence of HPV. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06224166
Study type Observational
Source Regina Elena Cancer Institute
Contact Giovanni Blandino, Doctor
Phone 06 52662911
Email giovanni.blandino@ifo.it
Status Recruiting
Phase
Start date January 17, 2023
Completion date January 17, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02864836 - Study of Copper Isotope in Head and Neck Cancer
Recruiting NCT05758389 - Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors Phase 2
Completed NCT01019954 - Photodynamic Therapy for Early Head and Neck Tumors Phase 1
Recruiting NCT05671458 - Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors N/A
Terminated NCT00528294 - Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area Phase 1
Recruiting NCT04671485 - Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) N/A
Completed NCT02855723 - Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable N/A